Shanxi C&Y Pharmaceutical Co.,Ltd.’s Net Profit Dropped 22.6% in First Quarter of 2023

Shanxi C&Y Pharmaceutical Co.,Ltd. (山西仟源医药集团股份有限公司) (300254.SZ) reported a net profit of 3 million yuan in the first quarter of 2023, down 22.6% year-on-year.

Meanwhile, the company posted 183.2 million yuan in revenue, down 4.5% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 911.9 million yuan in total liabilities, with a liability-to-asset ratio of 55.5%.